Fezolinetant’s efficacy and safety in treatment of vasomotor symptoms in postmenopausal women: a meta-analysis and GRADE evaluation of randomized controlled trials
Abstract Background Postmenopausal women are more likely to experience vasomotor symptoms (VMS), such as heat sensation and sweating. Recent trials have investigated fezolinetant in the treatment of VMS in postmenopausal women. Our study aims to conduct a meta-analysis of these trials in order to es...
Saved in:
| Main Authors: | Abdallah R. Allam, Mohamed Salah Alhateem, Abdelrahman Mohamed Mahmoud |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | European Journal of Medical Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40001-025-02279-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting vasomotor symptoms with the new drug fezolinetant – an expert overview
by: Rossella E. Nappi, et al.
Published: (2025-12-01) -
Characterization and Treatment Patterns of Peri/Menopausal and Postmenopausal Women with and Without Vasomotor Symptoms in a Retrospective Database Study
by: Lena Charafi, et al.
Published: (2025-01-01) -
Health status of perimenopausal and postmenopausal women at Mangalore, Karnataka, India
by: C V Divya, et al.
Published: (2022-01-01) -
Prevalence and impact of vasomotor symptoms associated with menopause among Nordic women: Subgroup analysis from an international cross‐sectional survey
by: Angelica Lindén Hirschberg, et al.
Published: (2025-08-01) -
The impact of surgical menopause on metabolic syndrome, bone mineral density, and vasomotor symptoms
by: F. N. Tuysuzoglu, et al.
Published: (2020-04-01)